2019 update to: Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

The American Diabetes Association and the European Association for the Study of Diabetes have briefly updated their 2018 recommendations on management of hyperglycaemia, based on important research findings from large cardiovascular outcomes trials published in 2019. Important changes include: (1) t...

Full description

Saved in:

Bibliographic Details
Published in:	Diabetologia Vol. 63; no. 2; pp. 221 - 228
Main Authors:	Buse, John B., Wexler, Deborah J., Tsapas, Apostolos, Rossing, Peter, Mingrone, Geltrude, Mathieu, Chantal, D’Alessio, David A., Davies, Melanie J.
Format:	Journal Article
Language:	English
Published:	Berlin/Heidelberg Springer Berlin Heidelberg 01.02.2020 Springer Nature B.V
Subjects:	Agonists Cardiovascular diseases Cardiovascular Diseases - metabolism Clinical trials Congestive heart failure Consensus Report Update Creatinine Death Diabetes Diabetes mellitus (non-insulin dependent) Diabetes Mellitus, Type 2 - drug therapy Diabetes Mellitus, Type 2 - metabolism Epidermal growth factor receptors Europe GLP-1 receptor agonists Glucagon Glucagon-Like Peptide-1 Receptor - agonists Glycated Hemoglobin A - metabolism Health risk assessment Heart failure Human Physiology Humans Hyperglycemia Hypoglycemia Hypoglycemic Agents - therapeutic use Internal Medicine Kidney diseases Medicine Medicine & Public Health Metabolic Diseases Patient-centered care Societies, Medical Sodium-glucose cotransporter Sodium-Glucose Transporter 2 Inhibitors - therapeutic use United States United States Europe Heart failure Patient-centred care Glucose-lowering therapy Hypoglycaemia Cardiovascular disease Chronic kidney disease Type 2 diabetes mellitus Guidelines
ISSN:	0012-186X, 1432-0428, 1432-0428
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!